Aerobiotix, Inc. to Exhibit and Sponsor Symposium at Infection Prevention Meeting
Published: Jun 12, 2018
Illuvia HUAIRS® combines a patented ultraviolet energy system and advanced filtration to eliminate airborne pathogens in the occupied hospital environment. This includes drug resistant microbes such as MRSA. “The hardest place to kill a pathogen is inside the human body. If we can eliminate the danger in the air before it gets a chance to enter the patient, the human and economic benefits are huge,” states David Kirschman, M.D., founder of Aerobiotix, Inc. At the APIC conference, Aerobiotix will be introducing the latest version of the Illuvia HUAIRS® system, which includes real-time monitoring and logging of air quality parameters in acute settings. “Real-time treatment and monitoring of air quality provides a new tool for infection preventionists to assure the most hygienic care environments are achieved in their facilities,” states Dr. Kirschman.
Aerobiotix will also be sponsoring a breakfast symposium for APIC attendees, The Next Generation SSI Bundle: Why You Should Consider the Operating Room Environment, which explore the correlation between the environment of the operating room and surgical site infection, with emphasis on the contribution of contaminated air to infections. Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC, will be the speaker, with Sue Barnes, RN, CIC, FAPIC as moderator. The session is Friday, June 15, 6:00-7:45 am, Room 208 A-D Minneapolis Convention Center, and offers a 1.8 CE certificate.
About Aerobiotix Inc.
Aerobiotix, Inc. is a company driving leadership in advanced air quality products for the acute care market. The company develops, manufactures and markets novel technologies to build better healthcare environments worldwide. Our focus is to build awareness of the contribution of air quality to hospital-acquired infections and provide safe, effective devices to improve environments of care. Today, our products benefit patients and caregivers around the globe.
Department of Marketing
Source: Aerobiotix, Inc.